https://www.patientpower.info/chronic-lymphocytic-leukemia/first-ever-car-t-therapy-approved-for-cll-sll

[cartwheels]

Promising, but unless I have read it wrong only 20% with complete response. What would be interesting is to know how many responded and for what duration

[Sushibruno]

so sad to see a very small percent.

[Steffi50]

I too felt stats were low. Would like to understand more about this.